Visit Technologyholdings.com
Focus Sector

CROs & Regulatory affairs

At Technology Holdings we have a strong reputation for working with Clinical Research Organisations (CROs). Our team of experienced professionals has worked closely with pioneers in the rapidly growing field and partnering with organizations that cover the entire spectrum of a drug’s lifecycle from discovery to commercialisation.

Our dedicated Healthcare and Life Sciences, which is spread across the Americas, Europe, and the Asia-Pacific, has advised on numerous strategic, operational and transactional projects to some of the biggest CRO’s including Iqvia, ICON NAMSA, Syneos Health.

At Technology Holdings we have extensive expertise and in-depth knowledge of working with clinical research organisations across multiple sub sectors including:

  • Clinical Trials & Clinical Operations Services
  • Biostatistics Services
  • Data management Services
  • Regulatory Compliance Services
  • Medical Writing Services
  • Pharmacovigilance Services

Representative Transactions

Representative Testimonials

Working with Technology Holdings was an absolute game-changer for our company. Their strategic guidance, unmatched expertise, and unwavering commitment were instrumental in navigating us through the complexities of the M&A process. TH acknowledged our distinctive proposition as the foremost design and engineering partner in the region, orchestrating a methodical and exceptionally professional M&A process to pinpoint the ideal strategic collaborator and attain a premium valuation for our enterprise. Leveraging their extensive network of buyers worldwide, they garnered multiple offers, leading to a successful outcome beyond our expectations. We couldn't have asked for a better partner in this critical endeavor. Thank you, TH, for your invaluable support and dedication. David Jones CEO, Design + Industry
We chose TH because of their track record in healthcare and life sciences. They truly became an extension of our company and took the lead in all aspects of the transaction. Their deep understanding of the transaction process and guidance through all the stages was invaluable. We truly couldn’t have done it without the TH team. When we started, we had excellent TH advisors, now we have wonderful friends. John Strapp Co-Founder & Chairman, The Kinetix Group
TH’s impressive track record in the Life Sciences Consulting, Data Science and Digital Transformation spaces was evident through their extensive network of industry buyer and investor relationships and deep understanding of the landscape. Their structured and highly professional sale process, combined with strategic insights and connections to key players in the industry, resulted in numerous offers. Their hard work and commitment to success resulted in an outcome that exceeded our expectations both in terms of valuation and fit. TH did the heavy lifting throughout the process, from creating compelling materials, facilitating extensive buyer/investor meetings, to managing due diligence and negotiations. The team was always responsive and worked hard to negotiate the optimal valuation and structure while guiding us through all the complexities and challenges of the process and consistently providing us with clear advice at each stage. TH truly became an extension of the SUAZIO team, just as they promised! NAMSA's strong heritage in the Life Sciences ecosystem makes them an excellent partner for us. Christophe Van der Linden Founder & CEO, SUAZIO
Technology Holdings’ global network, proven track record of transactions in technology solutions, digital transformation and life sciences, and extensive experience working with Salesforce and Microsoft partners made them an obvious choice as our advisor. From the very beginning, we were impressed with their thorough approach, their deep understanding of our business and their relentless commitment to helping us identify the right strategic acquirer. Technology Holdings were - without a doubt - critical to the success of the transaction, delivering multiple offers from a range of acquirers. In the end this meant we were able to find a partner with the ideal cultural fit, without compromising on valuation. We would highly recommend them to other business owners who are looking to take the next step in their company’s journey. Geert Adams Co-Founder and CEO, C-Clear and Atom Ideas
We are pleased to have chosen Technology Holdings as the advisory firm to work with us to find the right strategic fit. As a design and innovation services firm that focuses exclusively on healthcare, together with Veranex we can now offer a broader array of services to meet a growing demand from our clients. This year is shaping up to be a record year for our firm and Veranex is well positioned to help us sustain and accelerate our growth trajectory. We couldn't be more pleased with the Technology Holdings team, their understanding of the market and their process that delivered such a great outcome for us. Kai Worrell Chief Executive Officer, Worrell Design
From our first meeting, Technology Holdings recognized our unique proposition as a specialist strategic consultancy, providing evidence-based omnichannel customer engagement and digital transformation services and products to life sciences companies. TH ran a structured and highly professional sale process, securing a total of 12 offers from buyers globally, leveraging their extensive buyer relationships and deep expertise in the digital transformation and life sciences sectors. As we navigated through Covid-19, TH ensured that we capitalized on our unique proposition, selected the right strategic partner and secured a premium valuation for Across Health. We’d like to thank the TH team for their effort, resilience and for managing the heavy lifting at every step of the process, from preparing compelling material through to due diligence process management and negotiation. The level of advice provided from start to finish was of the highest calibre and was instrumental in ensuring that we found the ideal partner in Precision Medicine Group to continue our growth journey. We would certainly recommend Technology Holdings to any company considering a sale - their deep sector expertise and knowledge of the buyer landscape is truly unparalleled. Fonny Schenck Founder and CEO, Across Health
Technology Holdings is pleased to announce that it has acted as the exclusive financial advisor to SUAZIO, a leading data-driven Life Sciences and MedTech consultancy on its strategic sale to NAMSA, the world's leading MedTech CRO, an Archimed portfolio company headquartered in the United States.
More Focus Sectors

Healthcare BPO
Healthcare BPO
Healthcare BPO
Healthcare Providers
Healthcare Providers
Healthcare Providers
Digital Health & HealthTech
Digital Health & HealthTech
Digital Health & HealthTech
Med Tech
Med Tech
Med Tech
Biopharmaceuticals & Biotechnology
Biopharmaceuticals & Biotechnology
Biopharmaceuticals & Biotechnology
CDMOs & Laboratories
CDMOs & Laboratories
CDMOs & Laboratories
Healthcare AI, Analytics & Insights
Healthcare AI, Analytics & Insights
Healthcare AI, Analytics & Insights
Payer and Provider Services & Software
Payer and Provider Services & Software
Payer and Provider Services & Software
CROs & Regulatory affairs
CROs & Regulatory affairs
CROs & Regulatory affairs
Healthcare & Life Sciences Consulting
Healthcare & Life Sciences Consulting
Healthcare & Life Sciences Consulting
Healthcare & Life Sciences IT
Healthcare & Life Sciences IT
Healthcare & Life Sciences IT
Commercialization & Healthcare Communications
Commercialization & Healthcare Communications
Commercialization & Healthcare Communications